Study on Basal Joint Arthritis Prospective (BJAM)

June 4, 2025 updated by: Columbia University

Multicenter Prospective Study on Basal Joint Arthritis of the Thumb

The data in this prospective registry will be used 1) to define which surgical and nonoperative techniques are most effective at providing pain relief, restoring function, are cost effective, and patients are satisfied with their outcomes; and 2) to design focused clinical questions regarding the optimal treatment of basal joint arthritis of the thumb in future randomized controlled trials. There are no interventions or changes in patient care associated with this study.

Study Overview

Detailed Description

Basal joint arthritis of the thumb is a common condition associated with considerable morbidity. Many non-operative and operative treatments have been described but few multi-center prospective evidence based trials comparing standard treatments have been done. This continuing search for consensus of best clinical practices has been reviewed in a thorough meta-analysis of operative treatments for basal joint arthritis. Through the systematic collection of data regarding patient-specific characteristics, treatment interventions, and longitudinal functional outcome measurements the investigators believe patient outcomes and satisfaction can improve through the elucidation of risk factors for disease progression, and the timing and selection of treatment modalities, either conservative or surgical, for any particular patient. The establishment of a multi-center clinical registry will greatly facilitate these goals.

The study hypothesizes that there exist effective non-operative and operative treatments for certain patient populations with basal joint arthritis of the thumb. There also exists a functionally superior, cost effective, and low risk non-operative or minimally invasive operative treatment regime to alleviate pain and slow the progression of disease in those with less advanced disease. Likewise, there is significant functional, health utility, and economic advantage to surgically treating advanced basal joint arthritis with one of the popularized procedures currently in practice.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic
    • New York
      • New York, New York, United States, 10032
        • Columbia University/NY Presbyterian Hospital
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study subject population will consist of patients who are diagnosed with CMC arthritis of the thumb stages I, II, III, or IV. Recruitment of subjects will be the responsibility of the operating surgeon or a member of his clincal staff.

Description

Inclusion Criteria:

  • Patients who have symptomatic basal joint arthritis.
  • Patients who are capable of providing informed consent.

Exclusion Criteria:

  • Patients younger than 18 years old at the time of enrollment.
  • Patients with neuromuscular disease affecting the operated hand, not caused by the CMC operation.
  • Patients with known inflammatory arthritic conditions, such as rheumatoid or psoriatic arthritis.
  • Patients with a history of or current infection of the basal joint of the affected hand.
  • Patients who are demented or are unable to provide informed consent.
  • Patients unable to comply with study guidelines.
  • Patients who have metacarpophalangeal joint hyperextension are NOT excluded. These patients will be followed and if they receive a capsulodesis or other procedure at the MCPJ at the same time as their basal joint arthroplasty this will be noted in their data records.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flexion/extension range of MCP joint
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
Range of motion measured in degrees of the metacarpophalangeal (MCP) joint.
Baseline, 6 weeks, 3 months, 6 months, 1 year
Flexion/extension range of IP joint
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
Range of motion measured in degrees of the interphalangeal (IP) joint.
Baseline, 6 weeks, 3 months, 6 months, 1 year
Grip strength
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
This will be quantified with use of a Jamar dynamometer set in the second position.
Baseline, 6 weeks, 3 months, 6 months, 1 year
Key-pinch strength
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
A 30-lb pinch dynamometer will used to determine lateral key-pinch strength.
Baseline, 6 weeks, 3 months, 6 months, 1 year
Tip-pinch strength
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
A 30-lb pinch dynamometer will used to determine lateral tip-pinch strength.
Baseline, 6 weeks, 3 months, 6 months, 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average total costs per patient
Time Frame: Up to 1 year
Review or estimation of hospital and office bills including those for the prescribed therapy and/or splinting will be tallied for each patient.
Up to 1 year
Disability of Arm, Shoulder and Hand (DASH) score
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
A questionnaire designed to assess musculoskeletal disorders of the upper limbs.
Baseline, 6 weeks, 3 months, 6 months, 1 year
SF-36 questionnaire score
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
A questionnaire designed to validate general health: surveys physical functioning, performance in a physical role, performance in an emotional role, vitality, social functioning, bodily pain, general health perceptions, and mental health.
Baseline, 6 weeks, 3 months, 6 months, 1 year
Prevalence of arthritis progression
Time Frame: Baseline, 6 weeks, 3 months, 6 months, 1 year
Radiographs will be performed classify each patient within the Eaton 102 osteoarthritis staging system. Sequential radiographs will be examined for progression of joint abnormalities.
Baseline, 6 weeks, 3 months, 6 months, 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melvin P Rosenwasser, MD, Columbia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2007

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

June 16, 2011

First Submitted That Met QC Criteria

June 17, 2011

First Posted (Estimated)

June 20, 2011

Study Record Updates

Last Update Posted (Actual)

June 6, 2025

Last Update Submitted That Met QC Criteria

June 4, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Subscribe